Lorediplon

From Wikipedia, the free encyclopedia
Lorediplon
Lorediplon.svg
Clinical data
ATC code
  • None
Legal status
Legal status
  • In general: non-regulated
Identifiers
IUPAC name
  • N-{2-fluoro-5-[3-(thiophen-2-ylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methylacetamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H15FN4O2S
Molar mass394.42 g·mol−1
3D model (JSmol)
SMILES
  • O=C(c2cnn3c(c1ccc(F)c(N(C(=O)C)C)c1)ccnc23)c4sccc4
InChI
  • InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3 checkY
  • Key:NQPOCLFSADOXBR-UHFFFAOYSA-N checkY
  

Lorediplon (INN) is a nonbenzodiazepine of the pyrazolopyrimidine family that is being pursued as a treatment for insomnia but has not completed development.[1]

See also[]

References[]

  1. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN): Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2): 179.



Retrieved from ""